| WISeKey’s WISeSat.Space Subsidiary Successfully Launches Its 21st Satellite to Low Earth Orbit with SpaceX |
Globe Newswire |
03/30 |
07:36 |
| Elevar Therapeutics Announces FDA Acceptance for Review of New Drug Application for Lirafugratinib as Second-line Cholangiocarcinoma Treatment |
Globe Newswire |
03/30 |
07:31 |
| FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy |
Globe Newswire |
03/30 |
07:30 |
| Anavex Life Sciences Provides Comprehensive Regulatory Update |
Globe Newswire |
03/30 |
07:30 |
| Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update |
Globe Newswire |
03/30 |
07:30 |
| Bombardier Announces Extension of Consent Solicitation with Respect to its 7.35% Debentures due 2026 |
Globe Newswire |
03/30 |
07:30 |
| InflaRx Highlights Clinical Activity of Vilobelimab in Pyoderma Gangrenosum in Late-Breaker Oral Presentation at 2026 American Academy of Dermatology Annual Meeting |
Globe Newswire |
03/30 |
07:30 |
| BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026 |
Globe Newswire |
03/30 |
07:30 |
| Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program |
Globe Newswire |
03/30 |
07:25 |
| Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases |
Globe Newswire |
03/30 |
07:15 |
| Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update |
Globe Newswire |
03/30 |
07:05 |
| urban-gro, Inc. Positions for Entry into Multi-Billion-Dollar T20 Cricket Market with LPL Season Six Player Auction on May 15, 2026 via IPG Platform |
Globe Newswire |
03/30 |
07:05 |
| Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up Plan |
Globe Newswire |
03/30 |
07:05 |
| PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase from 2024 |
Globe Newswire |
03/30 |
07:03 |
| Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study |
Globe Newswire |
03/30 |
07:01 |
| Micron Biomedical Named to Fast Company’s 2026 List of World’s Most Innovative Companies for Addressing the Most Significant Bottlenecks in How Medicine is Made, Distributed and Administered |
Globe Newswire |
03/30 |
07:01 |
| Digital Realty Announces Final Close of $3.25 billion U.S. Hyperscale Data Center Fund |
Globe Newswire |
03/30 |
07:00 |
| 49 new Nova LFS buses for the Greater Hamilton Area |
Globe Newswire |
03/30 |
07:00 |
| Connect Biopharma Announces Positive Topline Data from its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD |
Globe Newswire |
03/30 |
07:00 |
| Terrestrial Energy Announces Fourth Quarter and Full Year 2025 Results |
Globe Newswire |
03/30 |
07:00 |
| Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm™ (dibutepinephrine) Sublingual Film |
Globe Newswire |
03/30 |
07:00 |
| Stanley Steemer Launches “Dirt Balls” Campaign to Reveal Cleaning Blind Spots In American Homes |
Globe Newswire |
03/30 |
07:00 |
| USA Rare Earth Reports Fourth Quarter and Full-Year 2025 Financial Results |
Globe Newswire |
03/30 |
07:00 |
| OROCO ANNOUNCES RESIGNATION OF CEO |
Globe Newswire |
03/30 |
07:00 |
| PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement |
Globe Newswire |
03/30 |
07:00 |
